Functional gastrointestinal disorders as a public health problem

Neurogastroenterology and Motility

Volumn 20, Issue SUPPL. 1, 2008, Pages 121-129

  Talley, N J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cost; Epidemiology; Irritable bowel syndrome

Indexed keywords

BIOLOGICAL MARKER;

COMORBIDITY; COST OF ILLNESS; DIGESTIVE SYSTEM FUNCTION DISORDER; DISABILITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSPEPSIA; HEALTH; HEALTH CARE; HUMAN; IRRITABLE COLON; MORBIDITY; MORTALITY; PATHOGENESIS; PATIENT; PHYSICIAN; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PSYCHIATRY; PUBLIC HEALTH PROBLEM; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT PLANNING;

ABDOMINAL PAIN; CONSTIPATION; DYSPEPSIA; GASTROINTESTINAL DISEASES; HUMANS; IRRITABLE BOWEL SYNDROME; PUBLIC HEALTH;

EID: 41949138443     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2008.01097.x     Document Type: Review

References (63)

1. Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference. New York, 19 22, June, 1946 signed on 22 July 1946 by the representatives of 61 states (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948.
2. Drossman DA. The Rome Foundation and Rome III. Neurogastroenterol Motil 2007 19 : 783 6.
3. Talley N, Spiller RC. Irritable bowel syndrome: a little understood organic bowel disease? Lancet 2002 360 : 555 64.
4. Faresjo A, Grodzinsky E, Johansson S, Wallander MA, Timpka T, Akerlind I. Population-based case-control study of work and psychosocial problems in patients with irritable bowel syndrome-women are more seriously affected than men. Am J Gastroenterol 2007 102 : 371 9.
5. Nyrop KA, Palsson OS, Levy RL et al. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Aliment Pharmacol Ther 2007 26 : 237 48.
6. Thompson WG, Irvine EJ, Pare P, Ferrazzi S, Rance L. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002 47 : 225 35.
7. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006 130 : 1480 91.
8. Saito YA, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ 3rd. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. [see comment]. Am J Gastroenterol 2000 95 : 2816 24.
9. Saito YA, Talley NJ, Melton LJ III., Fett SL, Zinsmeister AR, Locke GRI. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Motil 2003 15 : 687 94.
10. Locke GR 3rd., Zinsmeister AR, Fett SL, Melton LJ 3rd., Talley NJ. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 2005 17 : 29 34.
11. Barbara G, Wang B, Stanghellini V et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007 132 : 26 37.
12. Guilarte M, Santos J, de Torres I et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 2007 56 : 203 9.
13. Talley NJ, Walker MM, Aro P et al. Nonulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol 2007 25 : 1175 83.
14. Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health-care seeking and emerging risk factors. Gastroenterol Clin North Am 2005 34 : 189 204.
15. Chang FY, Lu CL. Irritable bowel syndrome in the 21st century: perspectives from Asia or South-east Asia. J Gastroenterol Hepatol 2007 22 : 4 12.
16. El-Serag HB, Talley NJ. Systematic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004 19 : 643 54.
17. Aro P, Storskrubb T, Ronkainen J et al. Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol 2006 163 : 1025 34.
18. Halder SL, Locke GRI, Schleck CD, Zinsmeister AR, Melton LJ III., Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology 2007 133 : 799 807.
19. Drossman D, Li Z, Andruzzi E et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence sociodemography, and health impact. Dig Dis Sci 1993 38 : 1569 80.
20. Talley N, Weaver A, Zinsmeister A, Melton LJ III. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992 136 : 165 77.
21. García Rodríguez LA, Ruigómez A, Wallander MA, Johansson S, Olbe L. Detection of colorectal tumour and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand J Gastroenterol 2000 35 : 306 11.
22. Agreus L, Svardsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastro-esophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001 96 : 2905 14.
23. Talley N, Boyce P, Jones M. Predictors of health care seeking for irritable bowel syndrome: a population based study. Gut 1997 41 : 394 8.
24. Shaheen NJ, Hansen RA, Morgan DR et al. The burden of gastrointestinal and liver diseases 2006. Am J Gastroenterol 2006 101 : 2128 38.
25. Levy RL, Von Korff M, Whitehead WE et al. Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastroenterol 2001 96 : 3122 9.
26. Patel RP, Petitta A, Fogel R, Peterson E, Zarowitz BJ. The economic impact of irritable bowel syndrome in a managed care setting. J Clin Gastroenterol 2002 35 : 14 20.
27. Longstreth GF, Wilson A, Knight K et al. Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. Am J Gastroenterol 2003 98 : 600 7.
28. Bertram S, Kurland M, Lydick E, Locke GR 3rd., Yawn BP. The patient's perspective of irritable bowel syndrome. J Fam Pract 2001 50 : 521 5.
29. Kalantar JS, Locke GR III., Zinsmeister AR, Beighley CM, Talley NJ. Familial aggregation of irritable bowel syndrome: a prospective study. Gut 2003 52 : 1703 7.
30. Farage MA, Miller KW, Berardesca E, Mailbach HI. Psychosocial and societal burden of incontinence in the aged population: a review. Arch Gynecol Obstet 2007 Nov 20 (Epub ahead of print).
31. Boreham MK, Richter HE, Kenton KS et al. Anal incontinence in women presenting for gynecologic care: prevalence, risk factors, and impact upon quality of life. Am J Obstet Gynecol 2005 192 : 1637 42.
32. Jelovsek JE, Barber MD, Paraiso MF, Walters MD. Functional bowel and anorectal disorders in patients with pelvic organ prolapse and incontinence. Am J Obstet Gynecol 2005 193 : 2105 11.
33. Dixon-Woods M, Critchley S. Medical and lay views of irritable bowel syndrome. Fam Pract 2000 17 : 108 13.
34. El-Serag HB, Olden KW, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002 16 : 1171 85.
35. Ringstrom G, Abrahamsson H, Strid H, Simren M. Why do subjects with irritable bowel syndrome seek health care for their symptoms? Scand J Gastroenterol 2007 42 : 1194 203.
36. El-Serag HB, Talley NJ. Health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther 2003 18 : 387 93.
37. Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 2000 95 : 67 71.
38. Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics 2006 24 : 21 37.
39. Dean BB, Aguilar D, Barghout V et al. Impairment in work productivity and health-related quality of life in patients with IBS. Am J Manag Care 2005 11 (Suppl. 1 S17 26.
40. Talley N, Gabriel S, Harmsen W, Zinsmeister A, Evans R. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995 109 : 1736 41.
41. Agreus L, Borgquist L. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics 2002 20 : 347 55.
42. Sandler R, Everhart J, Donowitz M et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002 122 : 1500 11.
43. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002 122 : 1140 56.
44. Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet 2007 369 : 946 55.
45. Whitehead WE, Palsson OS, Levy RL, Feld AD, Turner M, Von Korff M. Comorbidity in irritable bowel syndrome. Am J Gastroenterol 2007 102 : 2767 76.
46. Saito YA, Petersen GM, Locke GRI, Talley NJ. The genetics of irritable bowel syndrome. Clin Gastroenterol Hepatol 2005 3 : 1057 65.
47. Baraniuk JN, Casado B, Maibach H, Clauw DJ, Pannell LK, Hess SS. A chronic fatigue syndrome - related proteome in human cerebrospinal fluid. BMC Neurol 2005 5 : 22.
48. Liebregts T, Adam B, Bredack C et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007 132 : 913 20.
49. Kassinen A, Krogius-Kurikka L, Makivuokko H et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007 133 : 24 33.
50. Koloski NA, Boyce PM, Talley NJ. Somatization an independent psychosocial risk factor for irritable bowel syndrome but not dyspepsia: a population-based study. Eur J Gastroenterol Hepatol 2006 18 : 1101 9.
51. Locke GR 3rd., Lin SC, Talley NJ. Psychiatric disease and functional GI disorders in the community: more evidence for a casual link? Am J Gastroenterol 2005 100 : 248 9.
52. Talley NJ, Howell S, Poulton R. The irritable bowel syndrome and psychiatric disorders in the community: is there a link? Am J Gastroenterol 2001 96 : 1072 9.
53. Gwee KA, Leong YL, Graham C et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999 44 : 400 6.
54. Whitehead WE. Twin studies used to prove that the comorbidity of major depressive disorder with IBS is NOT influenced by heredity. Am J Gastroenterol 2007 102 : 2230 1.
55. Marshall JK, Thabane M, Garg AX, Clark WF, Salvadori M, Collins SM. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006 131 : 445 50.
56. Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003 98 : 1578 83.
57. Ruigomez A, Garcia Rodriguez LA, Panes J. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities. Clin Gastroenterol Hepatol 2007 5 : 465 9.
58. Drossman DA, Thompson WG. The irritable bowel syndrome: review and a graduated multicomponent treatment approach. Ann Intern Med 1992 116 : 1009 16.
59. Lembo A, Ameen VZ, Drossman DA. The irritable bowel syndrome: review and a graduated multicomponent treatment approach. Clin Gastroenterol Hepatol 2005 3 : 717 25.
60. Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med 1995 122 : 107 12.
61. Longstreth GF, Yao JF. Irritable bowel syndrome and surgery: a multivariate analysis. Gastroenterology 2004 126 : 1665 73.
62. Chang JY, Locke GRI, Schleck CD, Zinsmeister AR, Talley NJ. Chronic constipation is associated with poorer survival in a U.S. population. Am J Gastroenterol 2006 101 : S484.
63. Puhan MA, Schunemann HJ, Wong E, Griffith L, Guyatt GH. The standard gamble showed better construct validity than the time trade-off. J Clin Epidemiol 2007 60 : 1029 33.